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Glycan-arrayIn this study we evaluated the receptor-binding properties of recombinant soluble hemagglutinin (HA)
trimers (subtype H2 and H7) produced in insect S2 cells, human HEK293T or HEK293S GnTI(-) cells, which
produce proteins with paucimannose, complex or high-mannose N-linked glycans, respectively. The results
show that HA proteins that only differ in their glycosylation status possess different receptor ﬁne
speciﬁcities. HEK293T cell-produced HA displayed a very narrow receptor speciﬁcity. However, when treated
with neuraminidase this HA was able to bind more glycans with similar speciﬁcity as HEK293S GnTI(-) cell-
produced HA. Insect cell-produced HA demonstrated decreased receptor speciﬁcity. As a consequence,
differences in HA ﬁne receptor speciﬁcities could not be observed with the insect cell-, but were readily
detected with the HEK293S GnTI(-) cell-produced HAs.).
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Inﬂuenza A viruses are enveloped, negative-strand RNA viruses
with a segmented genome. They cause acute viral disease that affects
a large variety of animal species, including humans, pigs, horses, and
birds. Inﬂuenza A virus classiﬁcation is based on the antigenic
properties of their two surface glycoproteins, hemagglutinin (HA)
and neuraminidase (NA). All subtypes of HA (H1–H16) have been
identiﬁed in avian inﬂuenza A viruses. Birds are therefore considered
to be the reservoir from which all inﬂuenza A viruses in other species
originate (Webster et al., 1992). The HA protein is the most important
determinant of virulence and host switching as it binds to sialic acid-
containing cell surface receptors on epithelial cells (de Wit et al.,
2009; Shinya et al., 2006; yora-Talavera et al., 2009; Nicholls et al.,
2008). While avian viruses preferentially bind to sialic acids attached
to the vicinal galactose via a α2-3 linkage (Connor et al., 1994),
human viruses prefer the α2–6 linkage (Rogers et al., 1985; Rogers
and D'Souza, 1989).
HA is a homotrimeric type I transmembrane protein with an
ectodomain composed of a globular head and a stem region (Ha et al.,
2001; Wilson et al., 1981). The sialic acid moieties of the viral
receptors bind to a shallow depression at the top of the HA protein
(Chandrasekaran et al., 2008; Stevens et al., 2004;Wilson et al., 1981).HA receptor-binding afﬁnity was found to be affected by oligosac-
charide linkages adjacent to the receptor-binding site (Ohuchi et al.,
1997b; Ohuchi et al., 1997a; Gunther et al., 1993). In addition, a recent
study demonstrated that enzymatic truncation of the N-glycan
structures on HA increased receptor-binding afﬁnity, while decreas-
ing speciﬁcity towards disparate sialic acid ligands (Wang et al.,
2009).
Cross-species transmission is an important aspect of the epidemi-
ology of inﬂuenza A viruses. Although the requirements for and
mechanisms of inﬂuenza A viruses to cross the species barrier are still
poorly understood mutations in HA are known to be critical (Tumpey
et al., 2007). At the present time, the speciﬁcity of HA–receptor
interactions is most conveniently analyzed using glycan array
technology (Stevens et al., 2006a). Glycan array analyses can either
be performed using intact virus preparations or recombinant soluble
HA proteins. Intact virus preparations have obvious biosafety issues
when dealing with unknown viruses, while the growth of viruses in
cell culture or eggs may result in adaptive mutations in HA.
Recombinant soluble proteins therefore provide an attractive alter-
native (Stevens et al., 2006b). The production of soluble HA proteins,
the trimeric state of which is essential for effective binding to sialic
acid moieties can be relatively easily achieved once the sequence of
the particular viral genome has been determined.
With our research we aim to determine HA–receptor interactions
for various HAs, using recombinant soluble HA trimers. These trimers
can be produced in different cell types, such as insect cells, by using
among others the baculovirus expression system (Chandrasekaran et
18 R.P. de Vries et al. / Virology 403 (2010) 17–25al., 2008), or mammalian cells (Wei et al., 2008). These different cell
types produce, however, glycoproteins that carry different oligosac-
charide side chains. Although insect cells are able to produce N-linked
glycoproteins, the cells fail to elongate the trimmed N-glycan
precursors to produce complex terminally galactosidated and/or
sialylated N-glycans that are produced inmammalian cells (Kost et al.,
2005). Rather, the insect cells produce glycoproteins that carry
paucimannose N-glycans, containing three mannoses. As differences
in the glycosylation status of the recombinant HAs might interfere
with HA–receptor interactions, we ﬁrst speciﬁcally investigated this
aspect. Thus, we produced soluble avian inﬂuenza A virus H2 and H7
trimers, which are predicted to contain 7 and 4 glycan side chains,
respectively, using insect and mammalian cell expression systems.
Two types of mammalian cells were used: HEK293T and HEK293S
GnTI(-) cells (Reeves et al., 2002). While the former produce
glycoproteins carrying complex N-glycans, glycoproteins produced
in the latter contain high mannose glycans as these cells lack a
functional N-acetylglucosaminyltransferase I. The puriﬁed HA trimers
were subsequently analyzed for their ability to bind sialic acid
receptors using different assays. The results show that HA–receptor
interactions depend on the speciﬁc expression system used. HA
trimers produced in the insect cells bind sialic acid ligands with
decreased speciﬁcity when compared to the trimers produced in the
HEK293S GnTI(-) cells. HEK293T cell-produced HA displayed themost
narrow receptor speciﬁcity, which broadened after treatment of the
protein with neuraminidase to resemble the speciﬁcity of the
HEK293S GnTI(-) cell-produced HA. Differences in receptor speciﬁcity
between H2 and H7 proteins, which are derived from inﬂuenza A
viruses from different species of birds, could be demonstrated using
recombinant HA proteins produced in HEK293S GnTI(-) cells, but not
with the HA proteins made in the insect cells.
Results
Expression, puriﬁcation, and characterization of the HA trimers
As we aim to study HA–receptor interactions for a large panel of
recombinant HAs, we ﬁrst analyzed to what extent the speciﬁc
expression system used would affect this interaction, by using H2[N8]
(A/Herring Gull/DE/677/88) as amodel. In order to express a soluble,
trimeric HA ectodomain in either insect or mammalian cells, the H2
ectodomain-coding sequence was ﬁrst cloned into the appropriate
expression vectors. In both plasmids used, the HA-sequence was
preceded by a signal peptide-encoding sequence and followed by
sequences coding for the GCN4 isoleucine-zipper trimerizaton motif
(Harbury et al., 1993) and the Strep-tag II, the latter for puriﬁcation
purposes (Fig. 1A). Expression of the HA ectodomain was achieved by
transient transfection of the appropriate plasmid into either HEK293T
cells or HEK293S GnTI(-) cells or by the generation of stably
transformed Drosophila Schneider S2 cells. HA proteins secreted into
the culture media were puriﬁed using the Strep-tag technology and
subjected to gel electrophoresis followed bywestern blotting using an
antibody directed against Strep-tag II (Fig. 1B). The results show that
the HA ectodomains differ in their electrophoretic mobility depending
on the expression system used. The HA protein migrated as a discrete
band after expression in the insect cells or in the HEK293S GnTI(-)
cells, with the insect cell-produced HA migrating slightly faster. This
result is in agreement with the expected oligosaccharide modiﬁca-
tions of the proteins, as glycoproteins expressed in the GnTI(-) or the
insect cells will be homogenously modiﬁed by high mannose or
paucimannose N-glycans, respectively. In contrast, the HA protein
produced in the HEK293T cells, which appeared as a fuzzy band,
migrating slightly slower in the gel consistent with its more
heterogeneous and complex N-linked glycans. However, when the
HA proteins derived from the different expression systems were
treated with N-Glycosidase F (PNGase F) to remove all N-linkedglycans, they ran at the same position in the gel in agreement with the
HA proteins, expressed in the different cells, having identical protein
backbones and only differing in their N-linked glycosylation. The
positions of the glycan side chains were modeled into the structure of
a homologous H2 trimer (A/duck/Ontario/77; Protein Data Bank ID
2WR3) (Liu et al., 2009), which showed that 1 N-linked glycan is
present at the tip of H2 (Fig. 1E).
Next, the oligomerization state of the different HA proteins was
analyzedby gelﬁltration column chromatography (Fig. 1C). In all three
cases the bulk of the HA protein eluted with the velocity of an
oligomer, presumably a trimer, while only a minor fraction was found
as aggregates in the void volume. The mammalian cell-derived HA
oligomers were larger than those from the insect cells, which is in
agreementwith their different extent of N-glycosylation, although the
increase in size was greater than expected. Similar differences in gel
ﬁltration column chromatography for HAs produced in either
mammalian or insect cells were also reported by Wei et al. (2008).
To conﬁrm their trimeric nature, the HA preparations were subjected
to blue-native gel electrophoresis followed by western blotting (Fig.
1D). When the insect-derived HA protein was heat-denatured prior to
electrophoresis, three protein species appeared which very likely
correspond to HA monomers, dimers and trimers, of which the fastest
migrating monomeric form was most abundant. When the HA
preparations were analyzed directly, i.e. without heating, the major
part of the proteinmigrated at the position of the trimer. In conclusion,
soluble trimeric HA ectodomains, differing only in their oligosaccha-
ridemodiﬁcation, were expressed in the three expression systems and
easily puriﬁed.
Biological activity of the HA ectodomain trimers
The biological activity of the different HA preparations was studied
using hemagglutination and solid phase-binding assays. These studies
were performed with recombinant HA proteins precomplexed with
anti-Strep-tag antibody as detailed in the Materials and methods
section. The results of the hemagglutination assay are shown in Fig. 2A.
Clearly, the HA protein produced in the HEK293T cells was much less
capable of hemagglutinating chicken red blood cells than the insect
cell-derived (Fig. 2A) and the HEK293S GnTI(-)-produced HA protein.
No hemagglutinationwas observedwhen the red blood cells had been
treated with Vibrio Cholera derived neuraminidase (VCNA), when the
HA proteins had not been precomplexed with the antibody directed
against Strep-tag II, or after addition of only the antibody (data not
shown). HA proteins were also evaluated in a bovine fetuin solid
phase-binding assay. Fetuin is a blood glycoprotein that contains 3 N-
linked and 3 O-linked sialylated glycan side chains. Binding of HA was
measured by means of the horseradish peroxidase (HRP) conjugated
to the anti-Strep-tag II antibody as detailed in the Materials and
methods section. No binding was observed when the HA proteins had
been produced without a GCN4-trimerization tag, when the proteins
had not been precomplexed with antibody directed against the
puriﬁcation tag, when antibody was applied alone (data not shown),
or when fetuin had been treated with VCNA (Fig. 2B). All trimeric HA
proteins demonstrated a concentration dependent binding to fetuin.
The HA proteins derived from the insect or the HEK293S GnTI(-) cells
displayed a similar,muchhigher activity than theHAprotein produced
in the HEK 293T cells. Essentially similar results were obtained when
the HA proteins were used to bind to wells coated with either human
A549 cells or chicken DF-1 cells (Fig. 2C and D). The reduced ability of
the HEK293T cell-produced HA protein to bind to sialylated substrates
is in agreement with previous studies (Ohuchi et al., 1995; Wei et al.,
2008; Uhlendorff et al., 2009) which showed that removal of sialic
acids from the HA protein is important for efﬁcient substrate binding.
As shown in Fig. 2E, this was also the case in our experimental setup.
When the HA protein produced in the HEK293T cells was treated with
VCNA prior to elution from the Strep-Tactin beads it acquired the
Fig. 1. Expression of recombinant trimeric HA proteins. (A) Schematic representation of the HA expression cassettes used. The HA ectodomain encoding sequence was cloned in
frame with DNA sequences coding for a signal sequence, the GCN4 isoleucine zipper trimerization motif and the Strep-tag II under the control of either a CMV or a methallothionein
promoter for expression in mammalian or insect cells, respectively. (B) HA ectodomains expressed in insect (S2), HEK293S GnTI(-) cells [GnTI(-)] or HEK293T (293T) cells and
puriﬁed from the culture media were analyzed by SDS–PAGE followed by western blotting. The recombinant proteins were detected using a mouse anti-Strep-tag antibody. When
indicated samples were treated with PNGase F prior to electrophoresis. (C) Analysis of puriﬁed recombinant HA proteins by gel ﬁltration. The elution proﬁles of the different HA
proteins using a Superdex200GL 10-300 column are shown. The elution of a 232 kDa catalase control is indicated by the dotted line. (D) Blue native-PAGE analysis of the recombinant
HA proteins. The position in the gel of the momomeric, dimeric and trimeric ectodomain species observed after heating of the HA sample prior to electrophoresis is indicated. HAs
subjected to gel electrophoresis without prior heating migrated at the position of the trimer. (E) Ribbon representation of the structure of H2 (A/dk/Ontario/77; Protein Data Bank
ID 2WR3), N-linked glycans are displayed in red. All N-glycans are modeled by GlyProt (Bohne-Lang and von der Lieth, 2005), while the graphics are generated by Swiss-PdbViewer
(http://spdbv.vital-it.ch/).
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that of HA protein synthesized in the HEK293S GnTI(-) cells (Fig. 2E
and data not shown). Our results demonstrate that HA trimers
produced in all three expression systems are biologically active.
Sialic acid receptor-binding speciﬁcities of the different HA trimers:
glycan array analysis
HA proteins produced in the different expression systems were
characterized for their oligosaccharide binding speciﬁcity by
performing glycan array analyses in collaboration with the Consor-
tium for Functional Glycomics. To this end, the different HA trimers,
precomplexed with mouse antibodies directed against the Strep-tag II
(2:1 molar ratio), were subjected to an array containing approxi-
mately 400 different glycans. Glycan binding by the HA trimers was
monitored using an FITC-conjugated secondary anti-mouse IgG
antibody. The glycan array data, including the glycan structures, can
be accessed via the Web site of the Consortium for FunctionalGlycomics (http://www.functionalglycomics.org/static/index.shtml;
see the legends of Figs. 4 and 5 for direct links to the raw data). A
summary of the results is shown in Fig. 3. The HA protein produced in
the HEK293T cells exhibited considerably less glycan binding activity
than its counterparts produced in the other expression systems
(compare Figs. 3A with 3B and 3C and see Fig. 3E), consistent with our
earlier binding assays (Fig. 2). This 293T cell-produced HA protein
showed a preference for glycan structures containing 2 sialic acids. In
addition to these glycans the HA trimer produced in the HEK293S
GnTI(-) cells recognized many other glycans containing α2-3-linked
sialic acids (Fig. 3B and E), as did the HA trimer produced in the insect
cells. This latter trimer additionally bound to a variety of other glycans
containing α2-3-linked sialic acids, not recognized by the HEK293S
GnTI(-) derived HA (Fig. 3C and E).
To investigate the contribution of the terminal sialic acids to
the binding of complex glycosylated HA trimers, HA protein produced
in HEK293T cells was treated with VCNA before applying it to the
glycan array. The results are shown in Fig. 3D and E. Although
Fig. 2. Binding of recombinant trimeric HA proteins to various sialic acid containing substrates. Recombinant soluble HA trimers were complexed with a HRP-conjugated, mouse
antibody directed against the Strep-tag prior to their application in the different binding assays. (A) Hemagglutination of chicken red blood cells by HA protein expressed in insect
(S2), HEK293S GnTI(-) [GnTI(-)] or HEK293T (293T) cells is shown at different HA concentrations as indicated. Binding of the HAs to fetuin (B, E), fetuin treated with VCNA (B), A549
cells (C, E) or DF-1 (D, E) cells was detected using TMB substrate by reading the OD at 450 nm.When indicated recombinant HA protein expressed in HEK293T cells was treated with
VCNA prior to the binding assay (E).
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treated HA trimers than for the HEK293S GnTI(-) derived trimers,
almost all glycan structures bound by the latter HA were also bound
by the desialylated HA (Fig. 3E). In summary, our results show that
trimeric HA proteins that are produced in different expression
systems and hence differ only in the length of their N-glycans exhibit
different receptor ﬁne speciﬁcities. The speciﬁcity of HA–receptor
binding appears to decrease with the HA protein itself carrying
shorter glycan side chains (S2-HAbHEK293S GnTI(-)-HAbHEK293T-
HA). HA produced in the HEK293S GnTI(-) cells demonstrated a
speciﬁcity similar to that of the VCNA-treated HA protein produced in
the HEK293T cells.
Receptor-binding speciﬁcities of different HA subtypes
Finally, we studied whether HA proteins produced in the different
expression systems are suitable to distinguish between HA–receptor-
binding ﬁne speciﬁcities. Therefore, we compared the glycan array
binding proﬁle of the H2[N8] (A/Herring Gull/DE/677/88), which we
used so far, with that of another HA subtype derived from an inﬂuenza
A virus isolated from a different bird species: H7[N2] (A/turkey/NY/
4450-5/94). Also this HA protein carries a N-glycan at the tip of the
molecule. H2 and H7 are expected to have similar but different
receptor ﬁne speciﬁcities. The soluble trimeric H7 ectodomain wasexpressed in HEK293S GnTI(-) and insect S2 cells and puriﬁed as
described above. The trimeric nature of the soluble ectodomain was
conﬁrmed by gel ﬁltration and blue native gel electrophoresis, while
its ability to bind sialylated substrates was conﬁrmed by solid phase-
binding assays (data not shown). Next, glycan array binding proﬁles
were generated, the detailed results of which can be found on the
Web site of the Consortium for Functional Glycomics (http://www.
functionalglycomics.org/static/index.shtml). The results are com-
piled in Figs. 4 and 5. As for the H2 protein, more sialic acid-
containing ligands were recognized by the H7 protein produced in the
insect cells than by that derived from the HEK293S GnTI(-) cells
(compare Fig. 4A with B and C with D).
Comparison of the receptor ﬁne speciﬁcities of the two different
HA proteins revealed that all glycans recognized by H2 were also
bound by H7, provided the proteins had been produced in the insect
cells (compare Fig. 4A with C and see Fig. 4E). However, when
produced in the HEK293S GnTI(-) cells, the two proteins had clearly
different receptor ﬁne speciﬁcities, though many ligands were still
bound by both HAs (compare Fig. 4B with D and see Fig. 4F). In
general, it appeared that H2 produced in HEK293S GnTI(-) cells
preferred binding to type 1 chain glycans [Gal(β1→3)GlcNAc]
containing α2-3-linked sialic acids, except when these glycans were
fucosylated, while HEK293S GnTI(-) cell-produced H7 preferred
binding to α2-3-sialylated type 2 chain glycans [Gal(β1→4)GlcNAc].
Fig. 3. Glycan array analysis of HA trimers produced in the different expression systems. Glycan array analyses are shown for the HA proteins produced in HEK293T cells (293T; A and
D), HEK293S GnTI(-) cells [GnTI(-); B] and insect cells (S2; C). (E) The HA protein was treated with VCNA prior to the analysis (293T VCNA). Glycan array 4.0 (A, B, and C) or array 4.1
(D) was used. The raw data and the glycan structures can be accessed at the following Web sites: A; http://www.functionalglycomics.org/glycomics/HServlet?
operation=view&sideMenu=no&psId=primscreen_2622, B; http://www.functionalglycomics.org/glycomics/HServlet?operation=view&sideMenu=no&psId=primscreen_2621,
C; http://www.functionalglycomics.org/glycomics/HServlet?operation=view&sideMenu=no&psId=primscreen_2623, D; http://www.functionalglycomics.org/glycomics/
HServlet?operation=view&sideMenu=no&psId=primscreen_2725. Binding of HA to different glycans was measured in relative ﬂuorescence units (RFU) as indicated on the
Y-axis. The order of the different glycans arranged on the X-axis of graphs A–D is identical. (E) A Venn diagram demonstrates the overlaps observed in the different HA–receptor-
binding proﬁles. The surfaces of each of the ovals correspond with the number of glycans bound by the different HAs.
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α2-3-linked sialic acid, is shown in Fig. 4G.
This observation was conﬁrmed by comparing the relative
binding strength of H2 and H7 produced in HEK293S GnTI(-) cells
to type 1 and type 2 glycans. To this end the ratio of the ﬂuorescence
intensities of H2 and H7 (measured in RFU), was determined and
plotted as in Fig. 5A. The results show that type 1 chain glycans were
preferentially bound by H2 (valueN1), while H7 preferred binding to
type 2 chain glycans (valueb1). When the same procedure was
applied to the insect cell-derived HA proteins carrying pauciman-
nose glycans (Fig. 5B), the large majority of the type 1 or 2 chain
glycans appeared to be bound by H2 and H7 with similar efﬁciency.
However, as only a single concentration of the HAs was applied to the
glycan arrays, we cannot exclude that at lower concentrations
similar differences in receptor ﬁne speciﬁcities can be observed for
the insect cell-produced H2 and H7. In summary, differences inreceptor ﬁne speciﬁcities between different HAs could most readily
be observed with recombinant soluble trimeric HA ectodomains
produced in HEK293S GnTI(-) cells.
Discussion
One of the key factors in the epidemiology of inﬂuenza A viruses is
their adaptability to different sialic acid receptors occurring at the cell
surfaces of different species. It is now well established that this
adaptive potential most often is caused by subtle mutations in the
viral glycoproteins, providing the virus with improved binding
properties in its new host. Much less is known about the possible
inﬂuence on these binding properties of the glycans attached to the
viral surface glycoproteins, though previous reports support the
signiﬁcance of such effects (Ohuchi et al., 1995b; Wang et al., 2009d;
Wei et al., 2008b). Inﬂuenza A virus HAs, which constitute the
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ides side chains distributed across the trimeric ectodomain complex
(Vigerust et al., 2007), some of them located close to the sialic acidreceptor-binding surface depression. With the aim to study the
inﬂuence of the HA glycosylation states on receptor binding and to
develop tools for convenient analysis of binding speciﬁcities of
Fig. 5. Relative binding of H2 and H7 to type 1 and type 2 chain glycans. The ratio of the
relative ﬂuorescence units (RFU), which are a measure for the binding of the HAs to the
different sugars, of H2 and H7 for type 1 and 2 chain glycans (on the X-axis) is plotted.
Only those type 1 and type 2 chain glycans were included that showed signiﬁcant
binding by either insect cell-produced H2 or H7 (N4000 RFU). Type 1 and 2 chain
glycans are indicated by black and white boxes, respectively. A ratio higher than 1
indicates preferred binding by H2, while a ratio smaller than 1 indicates preferred
binding by H7. The large rectangles mark the ratios ranging between values 3 and 0.33.
The dotted line indicates a ratio of 1. The ratios are shown for HA proteins expressed in
HEK293S GnTI(-) (A) or insect S2 (B) cells.
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of soluble, variously glycosylated trimeric HAs. The resulting HAs,
identical in their protein structure but differing in their glycan
makeup, allowed us to compare the receptor-binding speciﬁcities of
HAs with 4 different glycosylation states.
The HA proteins produced in HEK293T cells demonstrated only
very limited receptor binding as demonstrated in the hemagglutina-
tion assay, solid phase-binding assays and the glycan array proﬁling.
In agreement with previous studies (Ohuchi et al., 1995; Wang et al.,
2009; Wei et al., 2008), removal of sialic acids from the HA protein
itself was important for efﬁcient receptor binding. The sialic acid-
containing oligosaccharide may interfere with the accessibility of the
receptor-binding site by steric hindrance or by electrostatic repulsion.
Alternatively, HA-bound sialic acid may completely ﬁll the receptor
pocket of another HAmolecule (HA–HA interaction). Indeed, both the
H2 and the H7 subtypes used in this study carry an N-linked glycan at
their tip, which may be bound to or interfere with the accessibility of
the receptor-binding site of the neighboring monomer. Either way,
the HA proteins containing sialylated N-glycans were only able to
bind to di-sialylated glycan structures (Fig. 3 and data not shown).
Apparently, only di-sialylated glycan structures are able to obviate theFig. 4. Fine speciﬁcity analysis of insect and mammalian cell-produced HA proteins. Glycan
insect cells (S2; A and C) or HEK293S GnTI(-) cells [GnTI(-); B and D]. The raw data for H7
http://www.functionalglycomics.org/glycomics/HServlet?operation=view&sideMenu=n
HServlet?operation=view&sideMenu=no&psId=primscreen_2620. Graphs A–D show bin
[RFU]). On the X-axis the sialylated glycans are grouped according to theα2-3 orα2-6 linkage
divided further into type 1 or type 2 chain glycans. Glycans that contain both type 1 and type
the HA glycan array 4.0 binding proﬁles of H2 and H7 expressed either in insect S2 cells (E) o
Lewis c (Sia Le c) and Siayl Lewis a (Sia Le a) and the type II chain glycans Sialyl Lewis x (Sia L
of these HAs to these different sugars, while – indicates the absence of HA binding. ■, ○, ♦steric hindrance or the electric repulsion caused by the sialylated
glycans on HA itself, or alternatively to effectively compete with the
HA glycans for binding with the receptor pocket.
Inﬂuenza A viruses normally contain HA proteins that carry
complex glycans that are desialylated by the viral neuraminidase. To
mimic this HA glycosylation status, we removed the sialic acids from
the HA protein produced in HEK293T cells. This desialylated HA
protein revealed a similar receptor speciﬁcity as when the HA protein
was produced in the HEK293S GnTI(-) cells. These observations are
consistent with a recent study (Wang et al., 2009), which demon-
strated that the association constants and calculated free energy
changes of H5, expressed either in HEK293S GnTI(-) or in HEK293T
cells followed by neuraminidase treatment, were very similar when
binding to sialylated substrates. From these results we assume that HA
produced in the HEK293S GnTI(-) cells display similar receptor
speciﬁcity as HA expressed in virus-infected cells, although desialy-
lated HA probably mimics the natural situation most.
Our results show that receptor-binding speciﬁcity of inﬂuenza A
virus HA is not only affected by the presence or absence of sialylated
glycans, but also by glycan length. HAs produced in the insect cells,
which carry paucimannose glycans exhibited decreased receptor
speciﬁcity, when compared to the proteins expressed in the HEK293S
GnTI(-) cells, which contain high mannose oligosaccharides. Consis-
tent with our results, enzymatic trimming of N-glycan structures on
HA was shown to increase receptor afﬁnity, while decreasing the
speciﬁcity (Wang et al., 2009). Complete elimination of the glycan
side chains either by treatment with PNGase F or by disruption of the
N-linked glycosylation consensus sequence increased the afﬁnity of
HA for its receptor to such an extent that release by neuraminidase
was severely impeded (Ohuchi et al., 1997a). The different HAs used
in these studies (Ohuchi et al., 1997a;Wang et al., 2009; this study) all
carry N-linked glycosylation sites at the top of the HA molecule.
Therefore, the length of the HA glycans is likely to also affect the
receptor-binding speciﬁcity of other HAs with N-linked side chains at
their tip.
The decreased speciﬁcity of the insect cell-produced HA probably
makes this protein less suitable to study receptor ﬁne speciﬁcities
than HA produced in the GnTI-lacking cells. This notion was
supported by comparing the glycan array binding proﬁles of H2 and
H7 derived from inﬂuenza A virus from herring gull and turkey,
respectively. These HAs were expected to exhibit comparable, but
different receptor-binding speciﬁcities. While both HAs demonstrated
clear preference for binding to sialic acids attached to the vicinal
galactose via a α2-3 linkage (Neu5Acα2-3Gal), regardless of the
expression system used, differences in ﬁne receptor speciﬁcity could
not be observed with the insect cell-, but were readily detected with
the HEK293S GnTI(-) cell-produced HA.
The comparison of the H2 and H7 glycan array proﬁles demon-
strated that binding of HA is not only determined by the linkage of the
terminal sialic acid to the vicinal galactose, but is also affected by the
linkage of the galactose to N-acetylglucosamine. Thus, while H2,
derived from a herring gull-virus, preferred binding to type I chain
glycans (Neu5Acα2-3Galβ1-3GlcNAc), H7, derived from a turkey-
virus, more readily bound to type 2 chain glycans (Neu5Acα2-
3Galβ1-4GlcNAc). Furthermore, H2 did not bind fucosylated type I
chain glycans, which might be explained by steric hindrance of the
fucose moiety. Our results are consistent with the results ofarray analyses are shown for the H2 (A and B) and H7 (C and D) proteins produced in
and the structures of the bound glycans can be accessed at the following Web sites: C;
o&psId=primscreen_2618 and D; http://www.functionalglycomics.org/glycomics/
ding of HA to sialylated glycans on Glycan array 4.0 (in relative ﬂuorescence units
of the sialic acid to the vicinal galactose. Glycans containingα2-3-linked sialic acids are
2 chains are also indicated. (E–F) Venn diagrams demonstrate the overlap observed in
r in HEK293S GnTI(-) cells (F). (G) Schematic structures of the type I chain glycans Sialyl
e x) and Sialyl lactosamine (Sia Lac) are shown. H2 or H7 indicates the preferred binding
, and ▲ represent N-acetylglucosamine, galactose, sialic acid and fucose, respectively.
24 R.P. de Vries et al. / Virology 403 (2010) 17–25Gambaryan and coworkers who showed that inﬂuenza viruses
isolated from distinct species of aquatic and terrestrial birds may
differ in their ﬁne receptor-binding speciﬁcity by recognizing the
structure of the inner parts of the Neu5Acα2-3Gal-terminating
receptors (Gambaryan et al., 2005; Gambaryan et al., 2008).
Successful cross-species transmission of inﬂuenza A virus usually
involves alterations in the HA receptor speciﬁcity, allowing the virus
to replicate efﬁciently within and spread efﬁciently between its new
host (Chandrasekaran et al., 2008; Connor et al., 1994; Kuiken et al.,
2006). Glycan array technologies may aid in the surveillance of animal
viruses by rapidly assessing HA receptor speciﬁcity in ﬁne detail
(Childs et al., 2009; Tumpey et al., 2007). The production of
recombinant HAs may be very useful for these analyses, as it obviates
the use of potentially dangerous viruses, while in addition receptor
adaptation of cell culture- or egg-grown viruses is prevented (Wang
et al., 2006; Widjaja et al., 2006). In this study we evaluated the effect
of producing recombinant HAs in different expression systems on
receptor-binding speciﬁcity. Our results show that the expression
system used, and hence the glycosylation status of the recombinant
protein, affects the receptor ﬁne speciﬁcity of HA.
Material and methods
Genes and expression vectors
pCIneo plasmid containing full-length HA of A/Herring Gull/DE/
677/88 H2 (GenBank accession no. AAA43096) and A/Turkey/NY/
4450/94 H7 (GenBank accession no. AAD26925) were a kind gift of
Dr. D.L. Suarez (Lee et al., 2006). Based on H3 numbering (Wilson et
al.), cDNAs corresponding to residues 18 to 523 were produced by
PCR, isolated and cloned into the pGEMTeasy vector (Promega, USA).
The HA ectodomain encoding cDNAs were subsequently cloned into
the pCD5 vector for efﬁcient expression in mammalian cells (Zeng et
al., 2008) or into the pMT-Bip vector (Invitrogen) for expression in
Schneider S2 cells (Kim et al., 2009). Both vectors were modiﬁed such
that the HA-encoding cDNAs were cloned in frame with DNA
sequences coding for a signal sequence, an artiﬁcial GCN4 isoleucine
zipper trimerization motif (RMKQIEDKIEEIESKQKKIENEIARIKK) (Har-
bury et al., 1993) and the Strep-tag II (WSHPQFEK; IBA, Germany).
Protein expression and puriﬁcation
pCD5 expression vectors containing the HA ectodomain-encoding
sequence were transfected into HEK293T and HEK293S GnTI(-)cells
(Reeves et al., 2002) using polyethyleneimine I (PEI) in a 1:5 ratio (μg
DNA:μg PEI). At 6 h post transfection, the transfection mixture was
replaced by 293 SFM II expression medium (Invitrogen), supplemen-
ted with sodium bicarbonate (3.7 g/l), glucose (2.0 g/l), Primatone
RL-UF (3.0 g/l), penicillin (100 units/ml), Streptomycin (100 μg/ml),
glutaMAX (Gibco), and 1.5% DMSO. Tissue culture supernatants were
harvested 5–6 days post transfection. HA proteins were puriﬁed using
Strep-Tactin sepharose beads according to the manufacturer's
instructions (IBA, Germany). When indicated, HA trimers bound to
Strep-Tactin beads were treated with VCNA for 3 h at 37 °C (2 μU/ml),
followed by three washing steps prior to elution of the protein from
the beads. Drosophila Schneider S2 cells were co-transfected with
pMT-Bip vector encoding the HA ectodomain and pCoBlast using
Cellfectin in a 19:1 ratio, and stable cell lines were selected according
to manufacturer's protocols (Invitrogen), using blasticidine selection.
Cells were kept under blasticidine pressure and cultured in serum-
free Insect Xpress Medium (Lonza, Belgium) at 28 °C. Protein
expression was induced with CuSO4 (500 μM). Culture supernatants
were harvested after 10 days. HA proteins were puriﬁed as described
above. HA protein expression and puriﬁcation were conﬁrmed by
SDS–PAGE followed by western blotting using a mouse anti-Strep-tag
antibody (IBA, Germany). When indicated, the HA proteins weretreated with PNGase F (NEB) prior to electrophoresis according to the
manufacturer's procedures in order to remove N-linked oligosacchar-
ides. Oligomerization status of the HA proteins was determined by
analyzing the elution proﬁle using a Superdex200GL 10-300 column
(GE Healthcare) and by blue native-PAGE analysis.
Biological characterization of recombinant HAs
Functionality of the HAs was assessed using different solid phase
assays as well as by analyzing the ability of the recombinant HAs to
hemagglutinate chicken erythrocytes. For the fetuin binding assay,
100 μg/ml fetuin per well was used to coat 96-well nunc maxisorp
plates. Recombinant HA was precomplexed with HRP-linked anti-
Strep-tag antibody (2:1 molar ratio) for 30 min at 0 °C prior to
incubation of limiting dilutions on the fetuin-coated plates (60 min,
room temperature [RT]). HA binding was subsequently detected using
tetramethylbenzidine substrate (BioFX) in an ELISA reader (EL-808
[BioTEK]), reading the OD at 450 nm. In the CellELISA assays,
essentially the same protocol was used, with the exception that DF-
1 and A549 (105 cells per well) were cultured in a 96 well plate, for
16 h at 37 °C and ﬁxed with 4% paraformaldehyde solution in
phosphate buffered saline (PBS) rather than coating the wells with
fetuin. The hemagglutination assay was performed according to
standard methods, brieﬂy; 2-fold dilutions of the HA-anti-Strep-tag
antibody complex were incubated with 0.5% chicken erythrocytes for
30 min, at RT.
Glycan array analysis
Microarrays were printed as described (Blixt et al., 2004). The
glycan array analysis of the HA proteins was performed as previously
described (Stevens et al., 2006a). Brieﬂy 200 μg/ml recombinant HA
was precomplexed with HRP-linked anti-Strep-tag antibody (2:1
molar ratio) for 30 min at 0 °C prior to incubation for 60 min on the
microarray slide under a microscope cover-glass in a humidiﬁed
chamber at RT. Microarray slides were subsequently washed by
successive rinses in PBS with 0.05%Tween and overlaid with a
AlexaFluor 488 anti-Mouse Ab. After repeated washes with PBS with
0.05%Tween, PBS, and deionized water the slides were immediately
subjected to imaging as described (Blixt et al., 2004).
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